1-3 of 3
Mariana Bleker de Oliveira, BSc
Close
Sort by
Journal Articles

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

Mariana Bleker de Oliveira, BSc, Angela Isabel Eugenio, BSc, Veruska Lia Fook Alves, PhD, Daniela Zanatta, PhD, Mihoko Yamamoto, MD PhD, Bryan Eric Strauss, PhD, Gisele W. B. Colleoni, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5658.
https://doi.org/10.1182/blood.V128.22.5658.5658
Published: 2016
Journal Articles

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Mariana Bleker de Oliveira, BSc, Veruska Lia Fook Alves, PhD, Angela Isabel Eugenio, BSc, Rodrigo Carlini Fernando, BSc, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5663.
https://doi.org/10.1182/blood.V128.22.5663.5663
Published: 2016
Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4434.
https://doi.org/10.1182/blood.V128.22.4434.4434
Published: 2016